84 related articles for article (PubMed ID: 3300775)
21. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
Faye JC; Fargin A; Bayard F
Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
[TBL] [Abstract][Full Text] [Related]
22. A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors.
Ratajczak T; Atrache V; Antes P; Comber M; Hähnel R
Steroids; 1988; 51(5-6):499-518. PubMed ID: 3242173
[TBL] [Abstract][Full Text] [Related]
23. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
Garcia M; Greene G; Rochefort H; Jensen EV
Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
25. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
Aliau S; Mattras H; Richard E; Borgna JL
Biochemistry; 1999 Nov; 38(45):14752-62. PubMed ID: 10555957
[TBL] [Abstract][Full Text] [Related]
26. A cytosol protease from the estrogen-resistant C3H mammary carcinoma increases the affinity of the estrogen receptor for DNA in vitro.
Baskevitch PP; Rochefort H
Eur J Biochem; 1985 Feb; 146(3):671-8. PubMed ID: 3882420
[TBL] [Abstract][Full Text] [Related]
27. Efficient and selective photoaffinity labeling of the estrogen receptor using two nonsteroidal ligands that embody aryl azide or tetrafluoroaryl azide photoreactive functions.
Pinney KG; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
Biochemistry; 1991 Mar; 30(9):2421-31. PubMed ID: 2001370
[TBL] [Abstract][Full Text] [Related]
28. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
Elliston JF; Zablocki JA; Katzenellenbogen BS; Katzenellenbogen JA
Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
[TBL] [Abstract][Full Text] [Related]
29. Effect of ATP on the regulation of the steroid binding activity of the oestradiol receptor.
Lahooti H; Thorsen T; Aakvaag A
J Steroid Biochem; 1990 Jul; 36(4):333-43. PubMed ID: 2168008
[TBL] [Abstract][Full Text] [Related]
30. The strong hydrophobic domain of the activated estrogen receptor of porcine uterus.
Murayama A; Fukai F
FEBS Lett; 1983 Jul; 158(2):255-8. PubMed ID: 6873279
[TBL] [Abstract][Full Text] [Related]
31. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
32. Analysis in vitro of uterine estrogen receptor conformation of young and old rats.
Tnakur MK; Kaur J
Mol Cell Biochem; 1991 Jul; 105(2):171-7. PubMed ID: 1922011
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the 4-hydroxytamoxifen (4-OHTAM) bound nuclear estrogen receptor from MCF-7 cells by limited proteolysis.
Geier A; Beery R; Haimsohn M; Lunenfeld B
J Steroid Biochem; 1987 Nov; 28(5):471-8. PubMed ID: 3682814
[TBL] [Abstract][Full Text] [Related]
34. Action of calpain on the basic estrogen receptor molecule of porcine uterus.
Murayama A; Fukai F; Murachi T
J Biochem; 1984 Jun; 95(6):1697-704. PubMed ID: 6088476
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
[TBL] [Abstract][Full Text] [Related]
36. Colocalization of Estrogen Receptors with the Fluorescent Tamoxifen Derivative, FLTX1, Analyzed by Confocal Microscopy.
Morales A; Marín R; Marrero-Alonso J; Boto A; Díaz M
Methods Mol Biol; 2016; 1366():163-173. PubMed ID: 26585134
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical and genetic evidence for specific antiestrogen binding sites.
Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
[TBL] [Abstract][Full Text] [Related]
38. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors.
Mor G; Amir-Zaltsman Y; Barnard G; Kohen F
Endocrinology; 1992 Jun; 130(6):3633-40. PubMed ID: 1597160
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of an estrogen-responsive element binding protein repressed by estradiol.
Gray WG; Gorski J
Biochemistry; 1996 Sep; 35(36):11685-92. PubMed ID: 8794749
[TBL] [Abstract][Full Text] [Related]
40. Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to neoplasia.
Maaroufi Y; Trivedi S; Leclercq G
Cancer Biochem Biophys; 1995 Nov; 15(2):67-78. PubMed ID: 8590437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
